Reggie Gold
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Reggie Gold has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Mehmet Veysel Yigit
University at Albany, State University of New York 1400 Washington Avenue
3 shared publications Emmett Hanson
University at Albany, State University of New York 1400 Washington Avenue
2 shared publicationsDong Hoon Lee
Department of Chemistry, University at Albany, State University of New York, 1400 Washington Avenue, Albany, New York 12222, United States
1 shared publication- Emmett Hanson
Department of Chemistry University At Albany State University of New York Albany New York USA
1 shared publication - Ken Halvorsen
The RNA Institute, University at Albany, State University of New York, Albany, NY, 12222 USA
1 shared publication Pavl Royzen
Department of Chemistry University At Albany State University of New York Albany New York USA
1 shared publication
Latest Publications
- 28 September 2026
- Published by Wiley in Small Methods
Split Activator Assembly via Aptamer Binding Enables CRISPR‐Cas12a Activation With Non‐Nucleic Acid Targets
The programmability of CRISPR‐Cas12a has enabled transformative advances in nucleic acid detection; however, extending its activation to non‐nucleic‐acid targets remains highly desirable. Here, we report a universal split‐activator strategy that enables programmable Cas12a activation in response to a small molecule and a protein. In this approach, a canonical activator is divided into two fragments (p1 and p2), such that Cas12a activation occurs only upon their simultaneous assembly. We integrate this mechanism with aptamer‐mediated conformation switching, wherein target binding destabilizes an aptamer‐p2 duplex, releasing p2 to complete the activator complex and trigger Cas12a nuclease activity. Using this design, we demonstrate selective recognition of the small‐molecule metabolite adenosine and the protein biomarker prostate‐specific antigen (PSA), with high specificity against structurally related controls. Signal generation is achieved using fluorescent DNA nanoclusters (DFN‐1), which undergo fluorescence decrease upon Cas12a‐mediated degradation. The system exhibits concentration‐dependent responses for both targets. Together, this work establishes a modular framework for coupling aptamer‐based molecular recognition to programmable Cas12a activation, expanding the functional scope of CRISPR systems beyond nucleic acids and enabling new opportunities in CRISPR‐Cas12a‐mediated detection.
- 28 September 2026
- Published by Wiley in Small Methods
Split Activator Assembly via Aptamer Binding Enables CRISPR‐Cas12a Activation With Non‐Nucleic Acid Targets
The programmability of CRISPR‐Cas12a has enabled transformative advances in nucleic acid detection; however, extending its activation to non‐nucleic‐acid targets remains highly desirable. Here, we report a universal split‐activator strategy that enables programmable Cas12a activation in response to a small molecule and a protein. In this approach, a canonical activator is divided into two fragments (p1 and p2), such that Cas12a activation occurs only upon their simultaneous assembly. We integrate this mechanism with aptamer‐mediated conformation switching, wherein target binding destabilizes an aptamer‐p2 duplex, releasing p2 to complete the activator complex and trigger Cas12a nuclease activity. Using this design, we demonstrate selective recognition of the small‐molecule metabolite adenosine and the protein biomarker prostate‐specific antigen (PSA), with high specificity against structurally related controls. Signal generation is achieved using fluorescent DNA nanoclusters (DFN‐1), which undergo fluorescence decrease upon Cas12a‐mediated degradation. The system exhibits concentration‐dependent responses for both targets. Together, this work establishes a modular framework for coupling aptamer‐based molecular recognition to programmable Cas12a activation, expanding the functional scope of CRISPR systems beyond nucleic acids and enabling new opportunities in CRISPR‐Cas12a‐mediated detection.
- Open Access
- 31 August 2026
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 26 (36) , 11988-11995
Invasive RNA Programs Optical Switching in DNA Nanoclusters for CRISPR Sensing
DNA-templated silver nanoclusters have regained attention due to recent advances in stability and tunable optical properties. Here, we report a highly regulated DNA-templated silver nanocluster (DFN2) that exhibits strong fluorescence at 561 nm and enables reversible, label-free fluorescence switching governed by nucleic acid hybridization. The fluorescence of DFN2 is efficiently quenched with complementary DNA or RNA and fully restored through invading RNA strand mediated displacement, enabling robust and programmable ON-OFF-ON optical control. We integrated this hybridization-responsive platform with CRISPR-Cas12a to construct a target-activated biosensing system. Upon recognition of a conserved genomic fragment from a foodborne pathogen Listeria monocytogenes, the activated Cas12a cleaves a regulator DNA, initiating a cascade of hybridization and strand-displacement reactions that restore nanocluster fluorescence through an invasive RNA. This strategy exhibits high specificity against conserved genomic regions from other foodborne pathogens. These findings establish DFN2 as programmable, enzyme-responsive optical reporters for rapid, sensitive, and modular point-of-care biosensing.
- 31 August 2026
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 26 (36) , 11988-11995
Open AccessInvasive RNA Programs Optical Switching in DNA Nanoclusters for CRISPR Sensing
DNA-templated silver nanoclusters have regained attention due to recent advances in stability and tunable optical properties. Here, we report a highly regulated DNA-templated silver nanocluster (DFN2) that exhibits strong fluorescence at 561 nm and enables reversible, label-free fluorescence switching governed by nucleic acid hybridization. The fluorescence of DFN2 is efficiently quenched with complementary DNA or RNA and fully restored through invading RNA strand mediated displacement, enabling robust and programmable ON-OFF-ON optical control. We integrated this hybridization-responsive platform with CRISPR-Cas12a to construct a target-activated biosensing system. Upon recognition of a conserved genomic fragment from a foodborne pathogen Listeria monocytogenes, the activated Cas12a cleaves a regulator DNA, initiating a cascade of hybridization and strand-displacement reactions that restore nanocluster fluorescence through an invasive RNA. This strategy exhibits high specificity against conserved genomic regions from other foodborne pathogens. These findings establish DFN2 as programmable, enzyme-responsive optical reporters for rapid, sensitive, and modular point-of-care biosensing.
- Top Cited PapersOpen Access
- 10 February 2026
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 11 (3) , 2774-2783
Cas12a-Programmed Modular CRISPR Cascade Reaction on Paper Supports for Dual-Mode Detection of Pathogenic Genomes
We developed an optical biosensing platform using cost-efficient and scalable paper support for the detection and identification of three major bacterial pathogens using fluorescent DNA-templated silver nanoclusters (FNPs) and an innovative CRISPR-Cas12a cascade reaction. The sensors were fabricated as ∼5 mm letter-shaped paper cutouts, with each letter representing a specific pathogen: "C" for Campylobacter jejuni, "E" for Shiga toxin-producing Escherichia coli, and "L" for Listeria monocytogenes. Detection was initially achieved via an ON-to-OFF mechanism, wherein target recognition by Cas12a led to FNP degradation and fluorescence loss using target strands identified from the conserved genomic regions from each pathogen. This platform successfully detected individual and multiple targets in all possible seven combinations. To enhance diagnostic clarity, we developed a two-step CRISPR-Cas12a cascade reaction enabling an ON signal output when the target is present, a more intuitive and desirable reporting format. In this design, the first Cas12a reaction detects the target and cleaves an activator strand, preventing activation of a second Cas12a reaction that would otherwise degrade FNPs. Consequently, fluorescence is retained in the presence of the target (ON-retention) and lost in its absence, providing a clear ON signal when the target is detected, and an OFF signal when it is not. Finally, we demonstrated both ON-to-OFF and ON-retention detection modes using the whole Listeria genome amplified by isothermal recombinase polymerase amplification, with reliable detection of as few as 40 full genomic copies using fluorescent images on paper substrates. This work represents a significant advancement in Cas12a-based biosensing, uniquely demonstrating multistep biochemical reactions directly on paper support, and offers a promising platform for low-cost, scalable pathogen detection in resource-limited settings.
- 10 February 2026
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 11 (3) , 2774-2783
Top Cited PapersOpen AccessCas12a-Programmed Modular CRISPR Cascade Reaction on Paper Supports for Dual-Mode Detection of Pathogenic Genomes
We developed an optical biosensing platform using cost-efficient and scalable paper support for the detection and identification of three major bacterial pathogens using fluorescent DNA-templated silver nanoclusters (FNPs) and an innovative CRISPR-Cas12a cascade reaction. The sensors were fabricated as ∼5 mm letter-shaped paper cutouts, with each letter representing a specific pathogen: "C" for Campylobacter jejuni, "E" for Shiga toxin-producing Escherichia coli, and "L" for Listeria monocytogenes. Detection was initially achieved via an ON-to-OFF mechanism, wherein target recognition by Cas12a led to FNP degradation and fluorescence loss using target strands identified from the conserved genomic regions from each pathogen. This platform successfully detected individual and multiple targets in all possible seven combinations. To enhance diagnostic clarity, we developed a two-step CRISPR-Cas12a cascade reaction enabling an ON signal output when the target is present, a more intuitive and desirable reporting format. In this design, the first Cas12a reaction detects the target and cleaves an activator strand, preventing activation of a second Cas12a reaction that would otherwise degrade FNPs. Consequently, fluorescence is retained in the presence of the target (ON-retention) and lost in its absence, providing a clear ON signal when the target is detected, and an OFF signal when it is not. Finally, we demonstrated both ON-to-OFF and ON-retention detection modes using the whole Listeria genome amplified by isothermal recombinase polymerase amplification, with reliable detection of as few as 40 full genomic copies using fluorescent images on paper substrates. This work represents a significant advancement in Cas12a-based biosensing, uniquely demonstrating multistep biochemical reactions directly on paper support, and offers a promising platform for low-cost, scalable pathogen detection in resource-limited settings.